Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial
Status:
Recruiting
Trial end date:
2026-03-01
Target enrollment:
Participant gender:
Summary
This Randomized Controlled Trial was to clarity the clinical feasibility of 3D-HDRA results
in guiding the drug use of interventional chemotherapy after primary liver cancer surgery.